Lexicon Pharmaceuticals, Inc. (LXRX)

Lexicon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Short-Term Investments	117.64	171.3	147.56	92.01	22.68	26.01
Cash & Short-Term Investments	117.64	171.3	147.56	92.01	22.68	26.01
Cash Growth	-57.12%	16.09%	60.37%	305.73%	-12.82%	-88.96%
Accounts Receivable	2.18	3.47	1.01	0.03	0.01	0.4
Inventory	0.17	0.23	0.38	-	-	-
Other Current Assets	32.73	4.53	5.13	2.48	2.16	5.05
Total Current Assets	145.08	246.19	176.55	140.87	88.92	157.72
Net Property, Plant & Equipment	6.59	7.32	7.51	8.48	3.45	0.3
Goodwill	44.54	44.54	44.54	44.54	44.54	44.54
Other Long-Term Assets	0.37	0.37	0.83	0.41	-	1.23
Total Assets	225.58	298.42	229.43	194.3	136.91	203.79
Accounts Payable	5.9	14.8	14.39	10.4	9.15	5.47
Accrued Expenses	11.48	30.45	17.16	12.78	12.97	29.69
Current Portion of Long-Term Debt	-	-	-	-	-	11.65
Unearned Revenue	17.46	-	-	-	-	-
Total Current Liabilities	34.84	45.25	31.55	23.17	22.12	46.81
Long-Term Debt	56.11	100.3	99.51	48.58	-	-
Long-Term Leases	-	-	-	5.42	1.19	-
Other Long-Term Liabilities	5.2	6.92	5.27	-	-	0.61
Total Long-Term Liabilities	61.31	107.22	104.77	54	1.19	0.61
Total Liabilities	96.14	152.47	136.32	77.18	23.31	47.42
Common Stock	0.37	0.36	0.25	0.19	0.15	0.14
Treasury Stock	-5.19	-4.62	-2.89	-2.06	-7.52	-4.84
Additional Paid-in Capital	2,124	2,117	1,863	1,709	1,609	1,561
Accumulated Other Comprehensive Income	-0.01	0.12	0.03	-0.43	-0.01	-0.01
Retained Earnings	-1,989	-1,967	-1,767	-1,590	-1,488	-1,400
Shareholders' Equity	129.44	145.95	93.11	117.12	113.6	156.37
Total Liabilities & Equity	225.58	298.42	229.43	194.3	136.91	203.79
Total Debt	56.11	100.3	99.51	54	1.19	11.65
Net Cash (Debt)	61.54	71	48.05	38.01	21.49	14.37
Net Cash Growth	-13.33%	47.76%	26.42%	76.89%	49.58%	-
Net Cash Per Share	0.17	0.22	0.22	0.23	0.15	0.13
Book Value	129.44	145.95	93.11	117.12	113.6	156.37
Book Value Per Share	0.36	0.46	0.42	0.71	0.78	1.41
Tangible Book Value	84.9	101.41	48.57	72.58	69.05	111.83
Tangible Book Value Per Share	0.23	0.32	0.22	0.44	0.47	1.01

Updated Aug 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q